Publication: 4278

Publication: 4278

Alliance A021502, Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair (Alliance A021502; ATOMIC)

DOI

URL

Google Scholar

Citation:: JCO vol 43 (17_suppl) LBA1

Meeting Instance:: ASCO 2025
Year:: 2025
Type:: Abstract
Sub type:: Plenary
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 4777

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:: Genentech
Grants:: U10CA180821, U10CA180882, U24CA196171; U10CA180886 (COG); U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG Oncology); U10CA180888 (SWOG);

Corr. Author:
Authors:: Frank A. Sinicrope Fang-Shu Ou Dirk Arnold Walter R. Peters Robert J. Behrens Christopher Lieu Khalid Matin Deirdre J. Cohen Samara Potter Wendy L. Frankel Ardaman Shergill Dennis Hsu Anke Reinacher-Schick Tyler Zemla Clare Gatten Eileen M. O'Reilly Jeffrey A. Meyerhardt

Networks:: IWORC, LAPS-CO070, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NY016, LAPS-OH007, LAPS-PA015, NY021, TX012, VCU

Study: Alliance-A021502
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: